Ratings CRH plc Irish S.E.

Equities

CRG

IE0001827041

Real-time Irish S.E. Other stock markets 11:55:00 2023-09-25 am EDT			5-day change	1st Jan Change
50.34 ^EUR	-.--%		-.--%	-.--%

Apr. 29	Fitch Maintains CRH's Ratings on Strong Business Profile, Operating Performance	MT
Apr. 25	UK-listed drugmaker Indivior seeks shareholder nod for US listing	RE

Summary

The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

Strengths

Over the last twelve months, the sales forecast has been frequently revised upwards.
Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
For several months, analysts have been revising their EPS estimates roughly upwards.
Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
Over the past four months, analysts' average price target has been revised upwards significantly.
There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.

Ratings chart - Surperformance

Sector: Construction Materials

	1st Jan change	Capi.	ESG Refinitiv
CRH PLC	-.--%	54.04B	-
MARTIN MARIETTA MATERIALS, INC.	+20.79%	37.19B	C+
VULCAN MATERIALS COMPANY	+15.17%	34.57B	C+
ULTRATECH CEMENT LIMITED	-5.06%	34.42B	B+
GRASIM INDUSTRIES LIMITED	+12.97%	19.41B	B+
AMBUJA CEMENTS	+18.96%	18.59B	B
HEIDELBERG MATERIALS AG	+18.41%	18.81B	A-
CEMEX, S.A.B. DE C.V.	+4.54%	12.03B	A-
SUMMIT MATERIALS, INC.	+4.34%	7.04B	C+
KNIFE RIVER CORPORATION	+19.82%	4.49B	-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes